ArticleInternational journal of general medicine2022
Efficacy and Safety of Gefitinib Plus Anlotinib for Patients with EGFR Positive Advanced Non-Small-Cell Lung Cancer: A Retrospective Exploratory Study.
Wen-Xia Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.